Sue's Story: A Journey with Lewy Body Dementia has been presented in Continuing Medical Education programs offered by Kaiser Permanente and other health systems; in nursing programs offered by ...
Researchers at Lund University in Sweden have made a major breakthrough in diagnosing Lewy body disease, a leading cause of dementia ... giving doctors a critical head start.
28, 2025 /PRNewswire/ -- Today, the Susan and Charles Berghoff Foundation announced the public release of its award-winning documentary film, Sue's Story: A Journey with Lewy Body Dementia ...
This Centre’s research aims to address the cause, cure, care, and prevention of Lewy body dementia. By considering all elements of the disease, this Centre will pave the way for new treatments that ...
Lewy Body Dementia is a brain disease that mainly targets people above 50. It’s an incurable disease that doesn’t allow the patient to lead an ordinary life; they won’t be able to do their everyday ...
However, medical conditions can sometimes affect posture. According to the Alzheimer’s Society, those with Lewy body dementia experience movement difficulties, such as changes to their posture ...
CervoMed Inc. announced that it will present topline results from its Phase 2b RewinD-LB study at the 8th International Lewy Body Dementia Conference in Amsterdam on January 31, 2025. The study ...
Anosmia appears to be common in dementia with Lewy bodies but not in pure Alzheimer’s disease. Objective: To determine whether anosmia improves discrimination between the Lewy body variant (LBV) of ...
DSM, Diagnostic and Statistical Manual. A literature search using Medline, Embase and Psychinfo was performed in July 2013, and repeated in March 2014 covering the period from 1984 to the present ...
Dementia with Lewy bodies is the third most common disease that causes dementia. Both risk genes and faulty genes can be involved in dementia with Lewy bodies. Dementia with Lewy bodies (DLB) is ...
29, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that topline results from the ...